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Articles
NEUROSCIENCE
Why Neuroscience Matters for Rational
Drug Policy
David M. Eagleman, Mark A. Correro &
Jyotpal Singh*
I. INTRODUCTION
Drug addiction is an ancient problem for society, leading to
crime, diminished productivity, mental illness, disease
transmission, and a burgeoning prison population. According to
the Bureau of Justice Statistics, nearly seven out of ten jail
inmates met the criteria for substance abuse or dependence in
the year before their admission.1 One study found that 35.6% of
convicted jail inmates were under the influence at the time of
 2010 David M. Eagleman, Mark A. Correro, & Jypotpal Singh.
* David M. Eagleman is a Ph.D. neuroscientist at Baylor College of Medicine
(BCM) (eagleman@bcm.edu). He is the founder and director of BCM’s
Initiative on Neuroscience and Law (www.neulaw.org). Mark A. Correro is a
practicing attorney specializing in criminal defense. He graduated from South
Texas College of Law where he was an editor for the South Texas Law Review
and a Langdell scholar in Constitutional Law. He has published fourteen
scholarly
articles.
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or
correromark@hotmail.com. Jyotpal Singh is a practicing attorney in Houston,
Texas and former research fellow in the Initiative on Neuroscience and Law at
Baylor College of Medicine.
1. BUREAU OF JUSTICE STATISTICS, U.S. DEP’T OF JUSTICE, SPECIAL
REPORT: SUBSTANCE DEPENDENCE, ABUSE, AND TREATMENT OF JAIL INMATES
1 (2002), available at http://www.ojp.usdoj.gov/bjs/pub/pdf/sdatji02.pdf
[hereinafter SUBSTANCE DEPENDENCE] (“In 2002, 68% of jail inmates reported
symptoms in the year before their admission to jail that met substance
dependence or abuse criteria.”).
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their criminal offense.2 The cost to society of drug abuse has
been estimated at $180.9 billion, of which $107.8 billion is
derived from drug-related crime.3 The linkage between drug
abuse and crime has been thoroughly established elsewhere.
Promising new developments relating to emerging knowledge
and technologies may provide a bridge between the failed
policies of the past and novel solutions in the future. Drug
addiction is rooted in the biology of the brain, and society’s best
hope for breaking addiction lies in new ideas for rehabilitation,
not in repeated incarceration.
The past two decades have witnessed remarkable
progress in understanding the neural basis of drug addiction.4
Chronic drug use leads to enduring physical changes in the
structure of the brain, and these are thought to undermine
what we understand as voluntary control.5 Drug addiction
manifests itself as an irrepressible drive to take a drug despite
its undesirable consequences.6 For decades it was thought that
drug addiction resulted from physical dependence on the drug;
because withdrawal symptoms could be serious, even lifethreatening, drug addiction was thought to be the same as
physical dependence. By contrast, a new way of thinking
suggests that drug addiction is more than dependence; it is the
result of a reconfiguration of the circuitry of the reward and

2. BUREAU OF JUSTICE STATISTICS, U.S. DEP’T OF JUSTICE, SPECIAL
REPORT: DRUG USE, TESTING, AND TREATMENT IN JAILS 1 (2000), available at
http://www.ojp.usdoj.gov/bjs/pub/pdf/duttj.pdf (showing that, in 1998, 35.6% of
convicted jail inmates, or 138,000 individuals, were under the influence at the
time of offense).
3. NAT’L INST. ON DRUG ABUSE, NAT’L INSTS. OF HEALTH, PRINCIPLES OF
DRUG ABUSE TREATMENT FOR CRIMINAL JUSTICE POPULATIONS: A RESEARCH
BASED
GUIDE
26
(2006),
available
at
http://www.drugabuse.gov/PDF/PODAT_CJ/PODAT_CJ.pdf (“In 2002, it was
estimated that the cost to society of drug abuse was $180.9 billion . . . a
substantial portion of which—$107.8 billion—is associated with drug-related
crime, including criminal justice system costs and costs borne by victims of
crime.”).
4. E.g., Alan I. Leshner, Addiction Is a Brain Disease, and It Matters,
278 SCI. 45, 45 (1997) (“Dramatic advances over the past two decades in both
the neurosciences and the behavioral sciences have revolutionized our
understanding of drug abuse and addiction.”).
5. Nora D. Volkow & Ting-Kai Li, Drug Addiction: The Neurobiology of
Behaviour Gone Awry, 5 NATURE REVS. NEUROSCI. 963, 963 (2004) (“[R]ecent
studies have shown that repeated drug use leads to long-lasting changes in the
brain that undermine voluntary control.”).
6. Id.
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decision-making systems, leading to increased cravings and
diminished impulse control. In other words, addiction may be
reasonably viewed as a neurological problem that allows for
medical remedies, just as pneumonia may be viewed as an
affliction of the lungs that allows for the same. As we progress
in our understanding of the underlying circuitry of addiction,
how that circuitry leads to drives, and how drugs hijack and
reregulate that circuitry, we have the opportunity to leverage
that understanding into more effective drug policy that rests on
treatment rather than punishment.
Part II briefly reviews the extent of the drug addiction
problem in the United States and describes where American
drug policy has fallen short in its attempts to move from
punishment toward rehabilitation. Part III reviews the modern
neuroscientific understanding of reward and addiction, building
the argument that treating addiction requires an
understanding of the neural mechanisms involved in reward
systems, craving, and impulse control. Given the growing
biological understanding of addiction, we argue that science
must play a critical role in reforming drug policy. Part IV
explores cutting-edge ideas that offer new hope for treating
addiction directly rather than resorting to repeated rounds of
incarceration. Here, we describe two innovative strategies—
cocaine vaccines and real-time feedback in neuroimaging—
which offer fresh approaches to rehabilitation and new
opportunities for dialogue regarding the problem of drug
addiction.
II. WHAT TO DO ABOUT DRUG ADDICTS?
A. HISTORICAL TENSIONS BETWEEN PUNISHMENT AND
REHABILITATION
For centuries, societies have grappled with complex
ethical questions about how to deal with drug addicts. In
Robinson v. California, Justice Douglas wrote that an approach
of moral condemnation “continues as respects drug
addicts . . . . [T]hose living in a world of black and white put the
addict in the category of those who could, if they would, forsake
their evil ways.”7 Rather than looking at drug addiction as a

7. Robinson v. California, 370 U.S. 660, 669–70 (1962) (Douglas, J.,
concurring).
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scientific and medical phenomenon, many continue to cast the
issue in moral terms. It is perhaps not surprising that the
criminal justice system has generally used retributive justice to
deal with addicts, much like it once did for the mentally ill.8
The retributive stance generally extols “just deserts” and
diminishes rehabilitative attempts, even those guided firmly by
physiological understandings of the underlying pathologies.
Nevertheless, rehabilitative efforts have made meaningful
appearances throughout the twentieth century.
In the twentieth century, American drug policy
vacillated between punishment and rehabilitation. For
example, in the mid-twentieth century, attempts to treat and
rehabilitate addicts, rather than simply incarcerate them,
dominated social policy.9 These developments were facilitated
by advances in psychology and psychiatry.10 At that time, even
the Supreme Court seemed to embrace rehabilitation rather
than retribution.
In 1962, the Supreme Court found unconstitutional a
California statute that made addiction a crime.11 The statute
stated that “[n]o person shall . . . be addicted to the use of
narcotics . . . .”12 Rather than criminalizing conduct, the
California statute mandated a minimum ninety day jail
sentence based on a person’s status as an addict.13 In striking
down the statute, the Court reasoned that addiction is a
physiological condition requiring treatment rather than

8. Id. at 668 (citing ALBERT DEUTSCH, THE MENTALLY ILL IN AMERICA: A
HISTORY OF THEIR CARE AND TREATMENT FROM COLONIAL TIMES 13 (Holley
Press 2008) (1937)).
9. Douglas Dennis, Foreword: A Consumer’s Report, 14 ST. LOUIS U. PUB.
L. REV. 1, 4 (1994) (“Following World War II reformers made their greatest
gains since the late 1800s . . . . ‘Rehabilitation,’ based on the ‘medical model,’
achieved penal prominence and credibility. Criminals could be ‘cured’ of the
‘disease’ of criminality, so the theory went, and returned ‘rehabilitated’ to
society.”).
10. Id. (“Sociologists, psychologists, and psychiatrists found fertile fields
behind bars in which to test experimental behavior-modification programs.”).
11. Robinson, 370 U.S. at 667 (“[A] state law which imprisons a person
thus afflicted as a criminal, even though he has never touched any narcotic
drug within the State or been guilty of any irregular behavior there, inflicts a
cruel and unusual punishment in violation of the Fourteenth Amendment.”).
12. Id. at 660 n.1.
13. Id. (“Any person convicted of violating any provision of this
section . . . shall be sentenced to serve a term of not less than 90 days nor more
than one year in the county jail.”).
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punishment.14
By the late 1960s, however, the failure of science to find
biological solutions for addiction led to increased skepticism
about rehabilitation in the Supreme Court. In 1968, the Court
rejected Leroy Powell’s argument that alcoholism excused him
from being drunk in public.15 Powell argued that his public
intoxication was not volitional and, therefore, punishing him
for it was cruel and unusual.16 The psychiatrist who testified in
the case acknowledged that there was no medical consensus
over a definition of alcoholism or whether alcoholism was a
disease; however, he asserted that the defendant, as a “chronic
alcoholic” was “not able to control his behavior.”17 But the
Court found his argument a stretch because it went “much too
far on the basis of too little knowledge.”18 At that time, there
existed a lack of effective treatment options and consensus
regarding treatment efficacy.19 Moreover, treatment facilities
and trained providers were scarce.20 Finally, without adequate
treatment and facilities, a civilly committed addict could be
held indefinitely without being criminally confined due to the
fact that he had virtually no chance of being successfully
rehabilitated.21 Finding no viable treatment alternatives, the
Court concluded that criminal process was still necessary.22
14. Id. at 667.
15. Powell v. Texas, 392 U.S. 514, 531–37 (1968).
16. Id. at 517.
17. Id. at 517–18.
18. Id. at 521.
19. Id. at 527. The Court noted:
There is as yet no known generally effective method for treating the
vast number of alcoholics in our society. Some individual alcoholics
have responded to particular forms of therapy with remissions of
their symptomatic dependence upon the drug. But just as there is no
agreement among doctors and social workers with respect to the
causes of alcoholism, there is no consensus as to why particular
treatments have been effective in particular cases and there is no
generally agreed-upon approach to the problem of treatment on a
large scale.
Id.
20. Id. at 528–29.
21. Id. at 529.
22. Id. at 530. Explaining its reasoning further, the Court went on to
state:
Faced with this unpleasant reality, we are unable to assert that the
use of the criminal process as a means of dealing with the public
aspects of problem drinking can never be defended as rational . . . . If,
in addition to the absence of a coherent approach to the problem of
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The 1970s heralded the “era of harsh prison sentences.”23
Between 1972 and 2000, the incarcerated population grew to
more than two million.24 According to recent studies, the “sharp
rise in incarceration for drug-related offenses” directly fueled
this increase.25 This trend was further driven by societal
problems in the 1980s, the crack cocaine epidemic began,26 and
with it came the “War on Drugs.”27 The role of crack was
implicated by researchers in the rise of violence and crime,28
leading to calls for longer prison sentences and cleaning up of
the streets.
By the 1990s, the trend began to shift back toward
rehabilitation. In 1990, President George H.W. Bush and
Congress officially designated the 1990s as the “Decade of the
Brain.”29 In parallel with the acceptance and developments of
neuroscience, the shift from a retributive criminal policy
toward a more rehabilitative stance has continued. Recent
government30 and American Bar Association31 data bear out

treatment, we consider the almost complete absence of facilities and
manpower for the implementation of a rehabilitation program, it is
difficult to say in the present context that the criminal process is
utterly lacking in social value.
Id.
23. Stephen A. Saltzburg & James R. Thompson, 2007 A.B.A. SEC. CRIM.
L.
REP.
2,
available
at
http://meetings.abanet.org/webupload/commupload/CR209800/newsletterpubs/
ReportI.PDF.121306.pdf.
24. E.g., Steven D. Levitt, Understanding Why Crime Fell in the 1990s:
Four Factors that Explain the Decline and Six that Do Not, J. ECON. PERSP.,
Winter 2004, at 163, 177.
25. Id.
26. Id. at 179.
27. E.g., Saltzburg & Thompson, supra note 23, at 2.
28. E.g., Levitt, supra note 24, at 179–80.
29. E.g., Edward G. Jones & Lorne M. Mendell, Assessing the Decade of
the Brain, 284 SCI. 739, 739 (1999).
30. See SUBSTANCE DEPENDENCE, supra note 1, at 8. The report indicates
that, in 2002, 47% of addict inmates participated in treatment or other
programs while under correctional supervision. Trends indicate that these
numbers are growing.
31. See Saltzburg & Thompson, supra note 23, at 4–8. The
recommendations urge governments to move away from pure incarceration
methods of punishment toward community supervision, deferred adjudication,
mental health treatment, and substance abuse treatment when the offender is
not a threat to the community, has not committed a predatory or other serious
crime, and lacks prior criminal history. The report explicitly acknowledges
lingering doubts about rehabilitation but attempts to assuage these doubts
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this trend, with examples coming from jurisdictions across the
United States. The American Bar Association’s 2007
recommendations demonstrate this shift. Currently, programs
across the nation are shifting from retribution to
rehabilitation.32 Promising changes such as the increased use
of drug courts,33 civil commitments, community-supervised
treatment programs, and other rehabilitative strategies are
beginning to supplant the old focus on incarceration.
Neuroscience is critical to this new wave of treatment and
rehabilitation.
Now, at the dawn of the twenty-first century, the
decades-long demand for punishment is straining the criminal
justice system. Recidivism rates are high. In fact, “more than
two-thirds of those being released from prison [are] rearrested
within three years of release, and 42% of parolees [are]
returning to prison or jail within 24 months of their
release . . . .”34 This prison exodus means that 650,000
prisoners are temporarily returning to their communities every
year. Do addicts benefit from their incarceration? If not, can we
do more to enhance treatment outcomes and potentially reduce
the future societal costs? Rather than cataloging addiction’s
cost to society, new neuroscientific developments illuminate
knowledge and technologies that provide a bridge between the

with evidence about the inefficacy of long prison sentences. Further, the report
emphasizes that cost-effective strategies will depend upon a balancing of
interests between protecting the public through incarceration and preventing
recidivism through rehabilitation.
32. Beginning in 1993 in Arkansas, community-based substance abuse
treatment, drug courts, and other measures have been combined under a
system that allows for dismissal of charges and expungement of records. This
program has seen significant drops in recidivism rates. In Connecticut, every
court now has access to substance abuse evaluations and outpatient treatment
programs, and the state has inpatient treatment programs for substance
abusers. These strategies have also shown reduced recidivism rates. In Kings
County, New York, repeat drug offenders facing prison time have access to
treatment programming. The Multnomah County, Oregon STOP program
provides certain drug offenders with the option to complete a treatment
program to avoid prosecution. In Kansas, a new program for non-violent drug
offenders provides a long-term treatment program. Particularly promising is
the program’s recognition that relapse is not necessarily a failure to recover.
Id. at 9–13.
33. E.g., Harris County District Courts Success Through Addiction
Recovery, http://www.justex.net/courts/drug/adult/default.aspx (last visited
Feb. 5, 2010).
34. Saltzburg & Thompson, supra note 23, at 3.
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doctrinal literature about criminal punishment and new
treatment solutions for the future.
B. SCIENTIFIC EXPLANATIONS OF BEHAVIOR
Many people share a concern about incorporating
scientific explanations for behavioral problems into the law,
and this may stem in part from historical misuse. As Zedi and
Goodenough state:
Incorporating biology into legal doctrine is . . . problematic. To the
extent that biological approaches had been included in the great
arguments of the twentieth century between fascism, communism,
capitalism, socialism, dictatorship and liberal democracy, they often
wore a distorted and appropriately discredited aspect that had more
to do with political expediency than with any accurate application of
the admittedly limited science of the times.35

Considering recent history, apprehension to the use of
science in making social policy is justified. “But that biology
should have been thus misused in the past is not a good reason
for not taking account of its findings in the future, always of
course with appropriate safeguards.”36
A second concern, also shared by many, is that a
neuroscientific understanding may exculpate criminals,
allowing them to “blame their brains” for their behavior. Most
people believe that there is some sense in which criminals
should be held responsible for their actions, irrespective of the
states of their brains, and therefore the idea of exculpation is
unpalatably. We suggest that this belief does not need to be a
concern. Societies will continue to remove dangerous people
from the streets. Explanation does not equal exculpation;
instead it can equal rational sentencing and customized
rehabilitation. Rehabilitative treatments remove the threat
addicts pose to innocent people and save society the associated
costs that would be incurred were the addicts incarcerated. In
this respect, a consequentialist or utilitarian approach may be
more effective and less expensive than retribution and
punishment. The ultimate issue, then, from a scientific
perspective, is not how the criminal justice system can exact
revenge for an evil act, but, instead, whether the underlying
problem can be fixed through utilization of what is known of
35. Semir Zeki & Oliver R. Goodenough, Law and the Brain: Introduction,
359 PHIL. TRANSACTIONS ROYAL SOC’Y OF LONDON B 1661, 1661 (2004).
36. Id.
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the neuroscience of addiction so that neither the addict nor the
next victim has to suffer.
We suggest that the most fruitful path is to forego the
arguments of responsibility in favor of concentrating
neuroscientific efforts on rehabilitation. The onus is on
neuroscience to prove that it has something to offer. If it can,
then the legal system can act accordingly to leverage those
assets. In this article we review the neuroscientific
understanding of addiction and propose new treatments for
breaking addiction and the consequent cycles of incarceration.
In this paper we illustrate how neuroscience can back up its
claims of addiction as a biological problem and bring actionable
solutions to the table.
III. NEUROSCIENCE AND ADDICTION
A. BIOLOGICAL UNDERPINNINGS
The human brain consists of hundreds of billions of cells
called neurons, and over a trillion cells called glia. The number
of connections between these cells amounts to between 60–240
trillion.37 The complex pattern of connectivity in the brain—its
‘circuitry’—is dynamic: connections between cells are
constantly blossoming, dying, and reconfiguring.38 The pattern
of connectivity in the brain determines behaviors, thoughts,
and capacities, and damage to the circuitry impairs these
functions.39
Although addiction may involve volitional choices early on,
it is best understood in the chronic state as a brain disease. As
Volkow and Li put it: “[D]rug addiction is a disease of the brain,
and the associated abnormal behaviour is the result of
dysfunction of brain tissue, just as cardiac insufficiency is a
disease of the heart and abnormal blood circulation is the
result of dysfunction of myocardial tissue.”40 The proposal that
addiction is biologically rooted is not new; however, modern
37. GORDON M. SHEPHERD, THE SYNAPTIC ORGANIZATION OF THE BRAIN 7
(2004); CHRISTOF KOCH, BIOPHYSICS OF COMPUTATION: INFORMATION
PROCESSING IN SINGLE NEURONS 87 (1999).
38. DAVID M. EAGLEMAN, PLASTICITY: HOW THE BRAIN RECONFIGURES
ITSELF ON THE FLY (forthcoming 2010).
39. DAVID M. EAGLEMAN, DETHRONEMENT: THE SECRET HEGEMONY OF
THE UNCONSCIOUS BRAIN (forthcoming 2010).
40. Volkow & Li, supra note 5, at 963.
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techniques have progressed our understanding of the neural
basis of addiction from general ideas to specific mechanisms. In
1968, the Supreme Court pointed out that incarceration was
still necessary as long as a real understanding of addiction and
useful methods of rehabilitation were lacking.41 Almost half a
century later, we are close to meeting that challenge.
The brain contains circuitry that properly guides
animals in cognitive functions such as decision-making,
motivation, learning, and emotion.42 These circuits, largely
involving the neurotransmitter43 dopamine (and hence referred
to as dopaminergic) seem to be almost identical across the
family tree of animal species44, which typically suggests deep
evolutionary importance. These systems evolved to guide
animals’ decisions in their pursuit of food, drink, and mates.45
Drugs of abuse hijack these reward and decision-making
systems. One of the first steps in addiction is reinforcement
from drug-induced increases in dopaminergic activity.46 In
other words, the drug is interpreted as a highly positive
stimulus, and the brain’s dynamic circuitry is reconfigured to
make the brain seek more of it.47 The same mechanisms that
normally lead to proper foraging (e.g., if you find a good food
source, you seek more of it), are now commandeered by the
drug. In this framework, addiction is understood as a normal
process gone awry.48
41. Powell v. Texas, 392 U.S. 514, 522–30 (1968).
42. See generally READ MONTAGUE, WHY CHOOSE THIS BOOK?: HOW WE
MAKE DECISIONS 335 (2006).
43. A neurotransmitter is a small chemical that is secreted from one cell
and detected by another. It is the main mode of communication between cells
in the brain. Although several different neurotransmitter types in the human
brain are implicated in addiction, dopamine is one of the main players.
44. Alison Abbot, Addicted, 419 NATURE 872, 872 (2002).
45. Id.
46. In other words, the drug causes increased levels of dopamine, and this
causes the brain to reinforce the last behavior (i.e., the taking of the drug).
Reinforcement is the same concept used with Pavlov’s dogs: by delivering food
after the bell, the bell becomes a predictor of reward.
47. A. David Redish, Addiction as a Computational Process Gone Awry,
306 SCIENCE 1944, 1945–46 (2004); Nora Volkow et al., Dopamine in Drug
Abuse and Addiction: Results from Imaging Studies and Treatment
Implications, 9 MOLECULAR PSYCHIATRY 557, 561–63 (2004); Rita Z. Goldstein
& Nora Volkow, Drug Addiction and Its Underlying Neurobiological Basis:
Neuroimaging Evidence for the Involvement of the Frontal Cortex, 159 AM. J.
PSYCHIATRY 1642, 1645–46 (2002).
48. Redish, supra note 477, at 1944; Volkow et al., supra note 477, at 557;
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As a consequence of the reinforcement, the brain
becomes physically dependent on the chemicals provided by the
drug taking. The number of neurotransmitter receptors49 for
the drug will often increase, which, in the homeostatic
environment of the brain, causes ripples of change throughout
the system—these changes include gene expression, protein
products, and neural networks.50 This re-wiring of the brain
often leads to dangerous consequences: when an addict stops
taking a drug, there can be severe negative withdrawal effects.
Anyone who has witnessed an alcoholic suffer through the
delirium tremens (which, in the worst cases, can be fatal) can
grasp that withdrawal symptoms are a factor in sustaining
addiction. For many decades, scholars theorized that drug
addiction results from an avoidance of these negative
withdrawal effects51—i.e., once a person is physically
dependent on a substance, withdrawal difficulties serve as the
basis of addiction. But certain clinical facts do not fit this
physical-dependence model of drug addiction. For example,
addicts will often detoxify entirely, moving past the initial
period of physical withdrawal symptoms, and then years later
they will re-commence their compulsive drug-taking. Thus, the
question remained why addicted brains continue to stay
addicted. The answer seems to be two-fold: increased craving
and diminished impulse control.
The first issue—craving—involves the maintenance of
drug addiction from conditioned sensory cues. That is, stimuli
associated with the drug (such as the location of drug-taking,
paraphernalia associated with the drug, and so on) begin to
drive cravings, and hence drug-seeking behavior. Under the
positive incentive theory, addicts continue to use drugs due to
see David M. Egelman et al., A Computational Role for Dopamine Delivery in
Human Decision-Making, 10 J. COGNITIVE NEUROSCI. 623, 629 (1998)
(implicating the dopaminergic system in human decision-making).
49. A neurotransmitter receptor is a specialized protein molecule situated
on the surface of cells. Chemical signals of the right shape (neurotransmitters)
attach to the receptor, initiating a cellular response.
50. A system is homeostasic if it adjusts its internal environment so as to
maintain stability. When new chemicals (e.g., drugs) are introduced into the
brain, adjustments take place at many levels and at many time scales. Eric J.
Nestler, Molecular Basis of Long-Term Plasticity Underlying Addiction, 2
NATURE REVS. NEUROSCI. 119, 122, 125–26 (2001).
51. Terry E. Robinson & Kent C. Berridge, The Psychology and
Neurobiology of Addiction: An Incentive-Sensitization View, 95 ADDICTION
(SUPPLEMENT 2) S91, S92 (2000).
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their cravings for the drug effects.52 This helps account for
factors which a physical dependence theory alone does not. For
example, former addicts tend to relapse more often if they find
themselves in a familiar environment that was previously
associated with drug use53—this suggests that it is the learned,
anticipated pleasure that drives these actions. In fact, one can
make predictions about the likelihood of relapse based on
responses (both physiological and subjective craving) triggered
by drug-related cues.54 Because of the role of conditioned drugrelated cues, craving reduction is now considered a major
target
for
interventions,
both
psychological
and
pharmaceutical.55 As discussed in Part III below, new
technologies may directly target the neural networks
underlying these subjective cravings.
The second contributor to addictive behavior is the
inability to control impulses.56 Normally, in the service of
52. Id. at S92–S93; see also Samuel M. McClure et al., A Computational
Substrate for Incentive Salience, 26 TRENDS IN NEUROSCI. 423, 423–24 (2003)
(proposing that dopamine is crucial to the initiation of reward-seeking
behavior).
53. NAT’L INST. ON DRUG ABUSE, supra note 3, at 19.
54. See Delwyn Catley et al., Absentminded Lapses During Smoking
Cessation, 14 PSYCHOL. ADDICTIVE BEHAVIORS 73, 75–76 (2000)
(demonstrating that relapses can occur, independent of craving, when the
subject is in a situation consistent with previous use patterns); see also Joel D.
Killen et al., Prospective Study of Factors Influencing the Development of
Craving Associated with Smoking Cessation, 105 PSYCHOPHARMACOLOGY 191,
195 (1991) (showing subjective craving to be a strong predictor of relapse); Joel
D. Killen & Stephen P. Fortmann, Craving is Associated with Smoking
Relapse: Findings from Three Prospective Studies, 5 EXPERIMENTAL &
CLINICAL PSYCHOPHARMACOLOGY 137, 140–41 (1997) (exploring subjective
craving as a predictor of relapse).
55. Arthur L. Brody et al., Attenuation of Cue-Induced Cigarette Craving
and Anterior Cingulate Cortex Activation in Bupropion-Treated Smokers: A
Preliminary Study, 130 PSYCHIATRY RES.: NEUROIMAGING 269, 277–79 (2004);
see also Paul M. Cinciripini et al., Combined Effects of Venlafaxine, Nicotine
Replacement, and Brief Counseling on Smoking Cessation, 13 EXPERIMENTAL
& CLINICAL PSYCHOPHARMACOLOGY 282, 289–90 (2005) (exploring the success
of multi-facet treatment approach in smoking cessation); Carlo C. DiClemente
et al., Readiness and Stages of Change in Addiction Treatment, 15 AM. J. ON
ADDICTIONS 103, 112–15 (2004) (examining the usefulness of a stages-based
model for addiction recovery).
56. Steven E. Hyman, The Neurobiology of Addiction: Implications for
Voluntary Control of Behavior, 7 AM. J. BIOETHICS 8, 9–10 (2007); see Antoine
Bechara et al., Different Contributions of the Human Amygdala and
Ventromedial Prefrontal Cortex to Decision-Making, 19 J. NEUROSCI. 5473,
5479–81 (1999) (implicating the amygdala in making advantageous decisions);
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longer-term goals, behavioral guidance signals will inhibit
urges. But in addicts, diminished inhibition allows the
unmasking of compulsive drug-seeking and drug-taking.57
Simple cognitive tasks that measure an individual’s capacity
for cognitive control, such as quickly inhibiting a motor
response, serve as strong predictors of treatment compliance
and relapse.58 In methamphetamine addicts, brain activity
while performing such simple tasks correlates with relapse up
to a year after cessation.59 Again, Part III leverages this
understanding to illustrate ways of targeting this deficit in a
specific manner.
B. WHY THE SCIENCE SHOULD SHAPE THE POLICY
The United States has a history of combating the drug
problem with increased law enforcement rather than

P.W. Kalivas et al., Unmanageable Motivation in Addiction: A Pathology in
Prefrontal-Accumbens Glutamate Transmission, 45 NEURON 647, 649 (2005)
(arguing that changes in brain functioning “result in the compulsive focusing
of behavior on drug associated stimuli . . . .”); Goldstein & Volkow, supra note
47, at 1643 (proposing that addiction results in a loss of willed behaviors).
57. Dan I. Lubman et al., Addiction, A Condition of Compulsive
Behaviour?: Neuroimaging and Neuropsychological Evidence of Inhibitory
Dysregulation, 99 ADDICTION 1491, 1492 (2004); see also Rita Z. Goldstein et
al., Severity of Neuropsychological Impairment in Cocaine and Alcohol
Addiction: Association with Metabolism in the Prefrontal Cortex, 42
NEUROPSYCHOLOGIA 1447, 1455–57 (2004) (comparing neuropsychological
impairment of cocaine addicts and alcoholics).
58. In essence, such an experiment would involve pressing a button when
cued to do so. In some trials, the participant is suddenly asked not to press the
button. People with high impulsivity are unable to stop themselves. As an
example of using simple cognitive tasks as outcome predictors, see W. Miles
Cox et al., Alcohol Attentional Bias as a Predictor of Alcohol Abusers’
Treatment Outcome, 68 DRUG & ALCOHOL DEPENDENCE 237, 242–43 (2002)
(demonstrating that among alcohol abusers, a relationship exists between less
distraction from alcohol-related stimuli and successful treatment); see also
Andrew J. Waters et al., Attentional Bias Predicts Outcome in Smoking
Cessation, 22 HEALTH PSYCHOL. 378, 383 (2003) (showing, among cigarette
smokers, that less distraction by tobacco-related stimuli is a predictor of
successfully quitting smoking); Chris C. Streeter et al., Performance on the
Stroop Predicts Treatment Compliance in Cocaine-Dependent Individuals, 33
NEUROPSYCHOPHARMACOLOGY 827, 832 (2008) (predicting methamphetamine
relapse with the amount of distraction caused by drug-related stimuli).
59. See Martin P. Paulus et al., Neural Activation Patterns of
Methamphetamine-Dependent Subjects During Decision Making Predict
Relapse, 62 ARCHIVES GEN. PSYCHIATRY 761, 765–66 (2005) (finding that
brain activity while performing a simple decision-making task is correlated
with relapse).
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customized intervention and rehabilitation. For years, experts
have weighed in on this topic and come to similar conclusions
about current drug policy. One author has stated: “[D]rug
treatment programs remain notoriously underfunded, turning
away tens of thousands of addicts seeking help even as
increasing billions of dollars are spent to arrest, prosecute, and
imprison illegal drug sellers and users.”60 Another author
approached the issue in this way: “The investment of more than
70% of the federal [U.S.] drug control money into supply
reduction seems misplaced . . . . Curtailing the supply of
demanded drugs has been compared to squeezing a balloon:
constrict it in one place and it expands somewhere else.”61
In light of the current science, it would appear there is a
better strategy for combating the drug trade: instead of
concentrating on controlling the supply, concentrate on
controlling the demand. Below we will consider biologicallybased strategies for addressing demand—those strategies that
are currently in use, and some that are on the horizon. The new
frameworks remove the emphasis on punishment in favor of
reducing craving while strengthening impulse control.
III. NEUROSCIENTIFIC STRATEGIES FOR
REHABILITATION
Cutting-edge ideas on the horizon offer new hope for
directly treating drug addiction rather than focusing on
punishment. We briefly outline the evidence-based strategies
currently in use. We then turn to two innovative strategies—
cocaine vaccines and real-time feedback in neuroimaging—
which offer fresh approaches and new opportunities for
dialogue in the problem of drug addiction. Such neurally-based
treatments can equip policy-makers with tools to treat
additions with maximal efficacy and minimum cost.
A. PHARMACEUTICAL STRATEGIES
Essentially there are two classes of pharmaceutical
intervention: those that obstruct the effects of the drug and its
reinforcing effects, and those that try to counterbalance
60. Ethan A. Nadelmann, Drug Prohibition in the United States: Costs,
Consequences, and Alternatives, 245 SCI. 939, 942 (1989).
61. Murray E. Jarvik, The Drug Dilemma: Manipulating the Demand, 250
SCI. 387, 389. (1990).
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changes to the brain brought on by the drug use.62 In the first
class, biological mechanisms include direct binding of the
medication to the receptors for the drug, or medications that
trigger negative sensations. The second class includes
medications that work to decrease the positive incentive of the
drug or increase the incentive of natural reinforcers.
For cocaine, several medications have been found to
reduce use. Some examples include disulfiram (a medication
with dopaminergic effects), GABA medications (tiagabine and
topiramate), a beta-adrenergic blocker (propranolol), and a
stimulant (modafinil).63
For alcoholism, medications like naltrexone are used to
antagonize64 the normal relationship of alcohol with its
receptors, thus interfering with reinforcement. Other
strategies, such as disulfiram, are used to trigger aversive
responses.
Heroin (and more generally, opiate) addiction is also
being treated with naltrexone (again as an antagonist for the
drug receptors), as well as with substitution strategies.65 Other
medications (e.g. methadone and buprenorphine) bind to the
opiate receptors with different kinetics, and thus reduce
craving and incentive by blocking the effects of the high.66 In
other words, these medications are intended to reduce craving
without inducing intoxication or later withdrawal symptoms.
In general, these measures reflect a conception of the
brain based mainly in neurotransmitter systems. Recently,
neuroscience has begun to develop a greater understanding of
the mechanisms at cellular and circuitry levels as well. This
62. Volkow & Li, supra note 5, at 967.
63. Mehmet Sofuoglu & Thomas R. Kosten, Emerging Pharmacological
Strategies in the Fight Against Cocaine Addiction, 11 EXPERT OPINION ON
EMERGING DRUGS 91, 91–94 (2006).
64. Antagonism is a concept in pharmacology in which one substance (the
antagonist) binds to the receptors that would normally be bound by a different
substance (in this case, the molecules of the drug), thereby blocking the drug’s
effects. See Noeline C. Latt et al., Naltrexone in Alcohol Dependence: A
Randomised Controlled Trial of Effectiveness in a Standard Clinical Setting,
176 MED. J. AUSTL. 530, 530–34 (2002).
65. Sandra D. Comer et al., Injectable, Sustained-Release Naltrexone for
the Treatment of Opioid Dependence: A Randomized, Placebo-Controlled Trial,
63 ARCHIVES GEN. PSYCHIATRY 210, 216–17 (2006).
66. See Eric E. Strain et al., Comparison of Buprenorphine and
Methadone in the Treatment of Opioid Dependence, 151 AM. J. PSYCHIATRY
1025, 1025 (1994).
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has opened the door to new strategies, two of which are
discussed below.
B. REAL-TIME FEEDBACK USING NEUROIMAGING
With new understandings come new opportunities for
more precise intervention. This is illustrated here with a new
approach to two targets: reducing craving and strengthening
impulse control.
As discussed above, subjective cravings triggered by
drug-related cues are considered main actors in clinical and
neuroscientific accounts of drug addiction.67 Therefore, craving
reduction—already a prime target of cognitive-behavioral,
psychotherapeutic, and pharmaceutical approaches—is one of
the prime objectives for new technologies. Dozens of functional
neuroimaging studies, mostly in nicotine and cocainedependent individuals, have highlighted a distributed network
of brain regions that show increased activity in response to
drug-related cues.68 Not coincidentally, the areas involved are
also implicated in normal reward processing, decision making,
and emotional responses. One area that deserves special
attention is an area of the cortex known as the insula, which is
involved in emotional responses. Activation of the insula is
strongly correlated with drug craving across different classes of

67. Arthur L. Brody et al., Neural Substrates of Resisting Craving During
Cigarette Cue Exposure, 62 BIOLOGICAL PSYCHIATRY 642, 642 (2007); Marcus
A. Gray & Hugo D. Critchley, Interoceptive Basis to Craving, 54 NEURON 183,
183 (2007); Rajita Sinha et al., Neural Activity Associated with Stress-Induced
Cocaine Craving: A Functional Magnetic Resonance Imaging Study, 183
PSYCHOPHARMACOLOGY 171, 171 (2005).
68. The distributed network involved in cue-triggered craving includes the
orbitofrontal cortex, dorsolateral prefrontal cortex, anterior cingulate cortex,
striatum, and insular cortex. Arthur L. Brody et al., Brain Metabolic Changes
During Cigarette Craving, 59 ARCHIVES GEN. PSYCHIATRY 1162, 1166–67
(2002); F. Joseph McClernon et al., Abstinence-Induced Changes in Self-Report
Craving Correlate with Event-Related fMRI Responses to Smoking Cues, 30
NEUROPSYCHOPHARMACOLOGY 1940, 1942 (2005); Stephen J. Wilson et al.,
Prefrontal Responses to Drug Cues: A Neurocognitive Analysis, 7 NATURE
NEUROSCI. 211, (2004) (proposing potential explanations for inconsistent
results between several neuroimaging studies); Thomas R. Kosten et al., CueInduced Brain Activity Changes and Relapse in Cocaine-Dependent Patients,
31 NEUROPSYCHOPHARMACOLOGY 644, 646–647 (2006); Teresa R. Franklin,
Limbic Activation to Cigarette Smoking Cues Independent of Nicotine
Withdrawal: A Perfusion fMRI Study, 32 NEUROPSYCHOPHARMACOLOGY 2301,
2305 (2007).
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drugs.69 Interestingly, damage to the insula disrupts subjective
urges to smoke, without changing the motivation of other
behaviors (such as eating).7071 These data point to the
distributed neural network involved in craving (and the insula
in particular) as prime targets for craving-reduction.
As mentioned above, there is another half to drug
addiction besides craving: deficits in impulse control.72
Neuroimaging has revealed a related network of areas involved
in cognitive control, involving areas known as the orbitofrontal
cortex (OFC), anterior cingulate cortex (ACC), and dorsolateral
prefrontal cortex (DLPFC). For example, cocaine addicts show
abnormal OFC and ACC activity,73 as well as diminished
DLPFC activity,74 hand-in-hand with diminished self-control
and poor performance on tasks that require inhibition of
impulsive responses. In chronic smokers, the brain’s reward
systems appear to function properly, but they are not engaged
in the normal way for the proper cognitive control signaling.75
These data suggest direct therapeutic interventions should be
used to enhance cognitive control in drug addicts.
How can we hope to directly affect specific brain
69. Brody et al., supra note 67, at 1167–68 (nicotine); Gene-Jack Wang et
al., Regional Brain Metabolic Activation During Craving Elicited by Recall of
Previous Drug Experiences, 64 LIFE SCI. 775, 777–779 (1999) (cocaine); L.A.
Sell et al., Neural Responses Associated with Cue Evoked Emotional States
and Heroin in Opiate Addicts, 60 DRUG & ALCOHOL DEPENDENCE 207, 214
(2000) (heroin); Katherine R. Bonson et al., Neural Systems and Cue-induced
Cocaine Craving, 26 NEUROPSYCHOPHARMACOLOGY 376, 379 (2002) (cocaine).
70. Nasir H. Naqvi et al., Damage to the Insula Disrupts Addiction to
Cigarette Smoking, 315 SCIENCE 531–34 (2007); Gray & Critchley, supra note
67, at 18386.
71. Gray & Critchley, supra note 67, at 18386.
72. Hyman, supra note 56, at 9–10; see also Antoine Bechara, Decision
Making, Impulse Control and Loss of Willpower to Resist Drugs: A
Neurocognitive Perspective, 8 NATURE NEUROSCI. 1458, 1458 (2005); Kalivas et
al., supra note 56, at 647; Goldstein & Volkow, supra note 47, at 1649.
73. Nora Volkow & Joanna Fowler, Addiction, a Disease of Compulsion
and Drive: Involvement of the Orbitofrontal Cortex, 10 CEREBRAL CORTEX 318,
320 (2000).
74. Robert Hester & Hugh Garavan, Executive Dysfunction in Cocaine
Addiction: Evidence for Discordant Frontal, Cingulate, and Cerebellar Activity,
24 J. NEUROSCI. 11017, 11019–20 (2004); Rita Z. Goldstein et al., The Effect of
Practice on a Sustained Attention Task in Cocaine Abusers, 35 NEUROIMAGE
194, 200–01 (2007).
75. Pearl H. Chiu et al., Smokers’ Brains Compute, but Ignore, a Fictive
Error Signal in a Sequential Investment Task, 11 NATURE NEUROSCI. 514, 517
(2008).
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networks? A new technology on the horizon—real-time
neurofeedback—suggests one possibility. Neuroimaging known
as functional magnetic resonance imaging (fMRI) allows the
viewing of neural activity. In a new development owing to the
introduction of fast computation and efficient algorithms, raw
data from the imaging can be reconstructed on-the-fly (in close
to ‘real-time’) and visually displayed in the scanner. In this
way, neural activity can be shown directly to an individual and
that person can attempt to modify it. This technique is known
as real-time fMRI, or rt-fMRI, or simply as neurofeedback.76
The approach is similar to the biofeedback strategies of
previous decades, except that it allows a view inside the skull,
giving a level of precision never before possible. This technology
has the potential to enable a dramatically new level of
sophisticated exploration of brain function that goes beyond
simple measurements of correlations between stimuli and their
associated fMRI activations. It puts the individual in the
driver’s seat of his own neural circuitry.77 To date, this
technology has been used to address pain and depression.
Neuroscience is leveraging this technology for a novel approach
to addiction. Specifically, rt-fMRI is being used to decrease
neural activations associated with craving and increase neural
activations associated with cognitive control. This strategy may
allow the overcoming of habitual responses to drug-cues in
addicts. We have begun this experimental endeavor here at
Baylor College of Medicine with nicotine addicts.78 It may be
almost a year before the efficacy of this approach can be
accurately gauged, but this integration of neural substrates of
addiction and real-time neuroimaging is highly promising. This
technology, together with other new developments, may

76. Stephen M. Laconte et al., Real-Time fMRI Using Brain-state
Classification, 28 HUMAN BRAIN MAPPING 1033, 1034 (2007); R. Christopher
deCharms, Reading and Controlling Human Brain Activation Using RealTime Functional Magnetic Resonance Imaging, 11 TRENDS COGNITIVE SCI.
473, 474–75 (2007); Nikolaus Weiskopf et al., Physiological Self-Regulation of
Regional Brain Activity Using Real-Time Functional Magnetic Resonance
Imaging (fMRI): Methodology and Exemplary Data, 19 NEUROIMAGE 577, 578
(2003).
77. In other words, users can view a graphical representation of the
amount of activity in particular areas of their brain (say, as a bar that moves
up or down), and they can work to control it.
78. This work is spearheaded by our colleagues Drs. Steven LaConte,
Pearl Chiu, Brooks King-Casas, and P. Read Montague.
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reinvigorate the discussion of possibilities for customized
rehabilitation.
C. THE COCAINE VACCINE
Another complementary approach circumvents the
continued reinforcement generated by the drug high. This
possibility is a drug vaccine, an intervention that renders the
individual unable to become high since the immune system will
“fight” the drug before it reaches the brain.79
A drug vaccination is accomplished in the traditional
biological manner of all inoculations: a foreign substance is
injected into the blood stream, and the immune system then
raises antibodies against the invader. In this case, the cocaine
molecule, which is attached to a large protein molecule, is
injected. The new antibodies come to recognize not only the
cocaine-protein complex, but also the naked cocaine molecule.
Now that the body has hosted an immune response, new
injections of cocaine into the bloodstream will be surrounded by
the body’s natural antibodies. In this way, the vaccination
prevents—or at minimum slows down—the crossing of the
cocaine molecules across the blood-brain barrier.80 The high is
thus eliminated or at least attenuated.81 Currently, the cocaine
vaccine is in clinical trials and shows early promise.
Dr. Tom Kosten, one of the lead developers of the
vaccine, sees the vaccine as most useful for addicts who desire
to stop using cocaine, but continue to be stymied by relapses.
The strategy is simple (if yet unproven): if an individual
vaccinates and then relapses, she will not find the expected
high, and her craving will eventually recalibrate. In other
words, she will lose interest.
If the vaccine works well, it could shift treatment from
counseling and rehabilitation programs to a mandatory
vaccination. There are, of course, some potential problems with
the notion of a drug vaccine. One is that addicts inoculated
79. Frank M. Orson et al., The Future of Vaccines in the Management of
Addictive Disorders, 9 CURRENT PSYCHIATRY REPS. 381, 381–87 (2007).
80. The blood-brain barrier is a collection of cells that protect the brain
from certain chemicals in the blood while passing others through.
81. Bridget A. Martell et al., Vaccine Pharmacotherapy for the Treatment
of Cocaine Dependence, 58 BIOLOGICAL PSYCHIATRY 158, 162 (2005); Laurent
Karila et al., New Treatments for Cocaine Dependence: A Focused Review, 11
THE INT’L J. OF NEUROPSYCHOPHARMACOLOGY 425 passim (2008).
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against cocaine may well turn to another drug for satisfaction,
and this highlights the importance of addressing the craving
and impulse control issues surrounding drug taking. As Robert
Julien notes: “Just as focus cannot be solely on the drug of
dependence
and
its
rewarding
and
withdrawal
effects . . . neither can it be only on pharmacotherapy for
treatment . . . . [A]ddicts will have to be able to handle later
exposure to craving-eliciting cues in the environment.”82
Vaccines in combination with neurofeedback may well prove to
be a fruitful combination.
IV. CONCLUSION
Drug addiction reflects abnormal operation of normal
neural circuitry. More than physical dependence, addiction
represents changes in the brain that lead to increased craving
and diminished capacity for the control of impulses. Given the
growing biological understanding of addiction, it is critical for
scientists to play an active role in drug policy. As
neuroscientific understanding develops, we will, to a much
greater degree, be able to target specific behavioral,
pharmaceutical, and neurological treatments for specific
addictions. It is important to emphasize that biological
explanation will not somehow become equivalent to
exculpation. Instead, the goal of explanation is to introduce
rational sentencing and the opportunity for customized
rehabilitation. This approach is likely to show more utility and
less cost than incarceration. The neuroscientific community
should continue to develop rehabilitative strategies so that the
legal community can take advantage of those strategies for a
rational, customized approach to drug addiction.

82. ROBERT M. JULIEN, A PRIMER OF DRUG ACTION 661 (10th ed. 2004).

